Skip to main content
Premium Trial:

Request an Annual Quote

Iconix Links DrugMatrix Database with MDL Information Systems Tools

NEW YORK, Jan. 14-Iconix Pharmaceuticals will link its DrugMatrix chemogenomics system with MDL Information Systems' open-platform database management tools, the two companies said today.


Chemists that subscribe to both systems will be able to use MDL ISIS search tools, which allow searches by chemical structure or structure similarity, to probe the genomic, toxicogenomic, and chemical information in the Iconix database.


The partnership offers chemists new ways to access genomic data in their drug discovery and testing work, said Iconix CEO Jim Neal in a statement.


Iconix Pharmaceuticals is a privately owned chemogenomics company based in Mountain View, Calif. MDS Pharma Services and Incyte are involvedin developing and commercializing DrugMatrix, and are both equity investors in the company.


MDL Information Systems is a subsidiary of Elsevier. It is based in San Leandro, Calif.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.